| BCBS Kansas | Filsuvez (birch triterpenes) Medical Drug Criteria | 2024-11-20 |
| BCBS Kansas | Lumbar Spinal Fusion | 2024-11-20 |
| HealthPartners | Gender-affirming care, surgical | 2024-11-20 |
| Medicare WPS | Billing and Coding: MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) (57571) | 2024-11-20 |
| Medicare WPS | Billing and Coding: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin (59259) | 2024-11-20 |
| Aetna | Sutimlimab-jome (Enjaymo) | 2024-11-18 |
| Aetna | Pozelimab-bbfg (Veopoz) | 2024-11-18 |
| Aetna | ADAMTS13, Recombinant-krhn (Adzynma) | 2024-11-18 |
| BCBS Highmark Penn Medicare Advantage | Teclistamab-cqyv (Tecvayli) | 2024-11-18 |
| Humana Medicaid | Community Brief Crisis Support (CBCS) - MEDICAID - LOUISIANA | 2024-11-17 |